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a  b  s  t  r  a  c  t
The  down-regulation  of  microRNA-328a  (miR-328a)  in  pentylenetetrazole  (PTZ)-kindled  rats  with  mem-
ory impairment  was  demonstrated  in  our  previous  study,  while  any  contribution  of  miR-328a  to cognitive
dysfunction  of  PTZ-kindled  rats remains  unknown.  In this  study  we  have  investigated  the  effect  and  the
underlying  mechanism  of  miR-328a  on  the  cognitive  function  in  PTZ-kindled  rats.  48 SD  male  rats  were
divided  into  4 groups  as follows:  a  PTZ kindled  group,  a miR-328a  antagomir  group,  an antagomir-control
group,  and  a  sham  group  (n  = 12  for each).  All  rats  except  those  from  the sham  group  were  treated  with
PTZ  14  times  at intervals  of  48 h to  establish  the temporal  lobe  epilepsy  (TLE)  models,  and  miR-328a
antagomir  was  given  to  the antagomir  group  as a treatment  by lateral-ventricle  injection  the day  after
the ﬁrst  injection  of PTZ.  Morris  water  maze  (MWM)  test  was  performed  to  assay  their learning  and  mem-
ory abilities.  The  down-regulation  of miR-328a  in the PTZ group  was  conﬁrmed  using  RT-qPCR  and  the
expression  of  miR-328a  was  diminished  after antagomir  treatment  (P < 0.05).  In the  probe  test  of water
maze,  the  time  and  distance  of the PTZ  group  were  both  shorter  than  those  of the  sham  group  (P  <  0.05),
and  those  of the antagomir-control  group  were  both  longer  than  those  of  the  antagomir  group  (P <  0.05).
In addition,  we  found  that  with  the down-regulation  of miR-328a,  the  levels  of Beta-site  APP-cleaving
enzyme  (BACE),  which  is  a bioinformatics-predicted  target  of miR-328a,  were  up-regulated.  These  ﬁnd-
ings suggest  that  miR-328a  may  play  a  role  in  memory  dysfunction  in PTZ-kindled  rats  by regulating  the
BACE  levels  and  this  links the  PTZ  model  with  Alzheimer’s  disease.
© 2016  The  Authors.  Published  by Elsevier  Inc. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Epilepsy is known to be a complex clinical syndrome character-
zed by different types of seizures with or without other speciﬁc
o-morbid disorders such as cognitive impairment, migraine,
epressive disorders, etc. (Bosak et al., 2012; Jabbehdari et al., 2015;
eidenberg et al., 2007). Memory impairment is one of the most
epresentative neuropsychological disorders in people with TLE
Seidenberg et al., 2007), and prior studies have experimentally
hown that the existence of seizures at an early age causes mem-
ry impairment in kainic acid (KA)-induced rat models (Sayin et al.,
004). Additionally, according to the previous testing in our labora-
Abbreviations: miR-328a, microRNA-328a; PTZ, pentylenetetrazole; TLE, tempo-
al lobe epilepsy; MWM,  Morris water maze; BACE, beta-site APP-cleaving enzyme;
PP, amyloid precursor protein; Abeta, amyloid beta; AD, Alzheimer’s disease.
∗ Corresponding author at: The First Afﬁliated Hospital, Guangxi Medical Univer-
ity, No 6 Shuangyong Road, Nanning, Guangxi 530021, China.
E-mail address: wuyuan90@126.com (Y. Wu).
ttp://dx.doi.org/10.1016/j.brainresbull.2016.07.008
361-9230/© 2016 The Authors. Published by Elsevier Inc. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
tory, a decline of memory ability occurred in a deﬁnite proportion of
rats kindled by pentylenetetrazole (Liu et al., 2015). There has been
evidence that the hippocampus plays a vital role in learning and
memory (Bohbot and Corkin, 2007), while some patients suffering
from recurrent epileptic seizures do not show signiﬁcant struc-
tural hippocampal damage in Magnetic Resonance Imaging (MRI)
(Holtkamp et al., 2004). Hence the underlying molecular mecha-
nisms of this prevalent feature among epileptics have aroused a
great deal of attention from researchers. Theories of the seizures
themselves, as well as antiepileptic drugs (AEDs) have been put
forward for the cause of cognitive dysfunction in epilepsy (Onuma,
2011).
Cognitive deﬁciency is known to be the clinical characteristic
of Alzheimer’s disease (AD), an age-related neurodegenerative dis-
order. The primary pathological change in AD is the presence and
deposition of amyloid beta (Abeta) peptides in brain, which is the
result of proteolytic cleavage reactions, a series of processes, start-
ing with amyloid precursor protein (APP), and mainly catalyzed
by the BACE (Dickson, 1997; Vassar et al., 1999). Furthermore,
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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beta contributes to the deterioration of cognitive function through
articipation in oxidative stress (Huang et al., 1999), restraint of
ong-term synaptic plasticity (Chen et al., 2000), electrolyte distur-
ance via forming the amyloid ion channels (Lal et al., 2007), etc.
herefore, BACE has been predicted to be a potential therapeutic
arget for treating AD (Vassar et al., 1999).
MicroRNAs (miRNAs) are endogenous noncoding RNAs com-
osed of approximately 22 nucleotides and they take a special role
n various human diseases by mediating the expression of their
arget messenger RNAs (mRNAs) which is supposed to be a pre-
ominant effect of inhibition through identifying and matching
ith the 3′-untranslated region of their targets (Guo et al., 2010).
t has been shown that miRNAs could regulate Abeta peptides lev-
ls by targeting BACE1 in AD (Boissonneault et al., 2009; Zhu et al.,
012). Additionally, previous study showed that miR-328a could
egulate the expression of BACE1 in mouse with AD (Boissonneault
t al., 2009). From our previous study, the down-regulation of miR-
28a in the hippocampus of TLE rats was by miRNA microarray
nalysis (Liu et al., 2015). In this study, the learning and memory
bility of rats were evaluated using Morris water maze, and RT-
PCR was performed to evaluate the expression of miR-328a in the
ippocampus. Target genes of miR-328a were predicted using Tar-
etScan, and the expression of the bioinformatics-predicted target
as evaluated by western blot assays.
. Materials and methods
.1. Animals and grouping
A total of 48 adult male Sprague-Dawley (SD) rats that were
–7 weeks old and weighed 220–240 g (Animal Experiment Cen-
er, Guangxi Medical University, China) were housed under proper
onditions (24 ± 2 ◦C; a 12-h light/dark cycle with lights on at
:00 a.m.). Fresh food and water were available. All animals were
reated appropriately according to the Guide for the Care and Use
f Laboratory Animals (National Research Council). Experimental
rocesses were approved by the Guangxi Medical University Ani-
al  Experimentation Committee. All reagents used in this study
ere purchased from commercial suppliers and were of an analyt-
cal level requiring further puriﬁcation. By using a random number
able, all rats were grouped as follows: PTZ group, miR-328a
ntagomir group, antagomir-control group, sham group (n = 12 for
ach group).
.2. Kindling and lateral-ventricle injection
The TLE model was established by giving the rats intraperi-
oneal injections of PTZ (Sigma-Aldrich, St. Louis, MO,  USA). On the
rst day, PTZ group, miR-328a antagomir group and antagomir-
ontrol group were given a single intraperitoneal injection of PTZ
60 mg/kg). After the ﬁrst injection of PTZ, repeat single injections
f PTZ (35 mg/kg) were performed 13 times at 48 h intervals. In
0 min  after the PTZ administration, rats were considered as TLE
odels if their behavioral changes reached level IV–V according to
he Racine standard (level 0, no change in behavior; level I, chew-
ng; level II, gazing and head nodding; level III, unilateral forelimb
lonus, twitching, and scratching; level IV, rearing with bilateral
orelimb clonus; level V, widespread muscle spasms, rearing with
ilateral forelimb clonus and falling back). Rats in the sham group
ere injected by the same dose of 0.9% physiological saline instead
f PTZ. Lateral-ventricle injections were given to the rats in the
iR-328a antagomir group and the antagomir-control group 24 h
fter their ﬁrst kindling. Rats anesthetized with 10% chloral hydrate
4 ml/kg) were ﬁxed in a stereotaxic apparatus (Paxinos). The cran-
otomy was performed with a needle ﬁtted to a 5 ml  syringe atletin 125 (2016) 205–210
the following coordinates: bregma: −0.8 mm;  laterality: 1.3 mm;
depth: 3.7 mm.  Then, each rat from the miR-328a antagomir group
was given a single intracerebroventricular injection of rno-miR-
328a antagomir (Guangzhou Ruibo Biological Technology Co. Ltd.)
and rats from the antagomir-control group were given antagomir
control (Guangzhou Ruibo Biological Technology Co. Ltd.). The dose
of the antagomir is 4 nmol, and the total volume for each rat is 10 ul.
2.3. Morris water maze test
The spatial learning and memory ability of rats were tested and
analyzed using the Morris water maze (Panlab, Barcelona, Spain).
Ink was added in order to make the platform invisible. Reference
items were placed around the pool so that the rats could use them
for spatial orientation and remained unchanged during the experi-
mental period. The data were produced by SLY-WMS MWM  system
v. 2.1.
The four-trial-per-day training of rats in the water maze that
lasted for ﬁve consecutive days was  conducted 24 h after the last
injection of PTZ. A maximum time of 90 s was  available for each
experimental rat to ﬁnd the hidden platform underwater. Each trial
had a different starting point, and if they failed to ﬁnd the platform
in 90 s, the rats would be guided to the platform manually and kept
at the platform for 10 s. The time spent by each rat to reach the
platform (i.e., the escape latency period) was  recorded, 90 s at most.
Spatial probe test was  conducted on the sixth day. The entire test
lasted for 90 s. The platform was removed and each rat was  released
opposite the target quadrant (the southeast quadrant), facing the
wall of the pool. In the probe test, time and distance that rats spent
in the target quadrant were recorded to assess their spatial memory
ability.
2.4. Tissue dissection and reverse transcription-qPCR for
miR-328a
The hippocampal tissue was  harvested and stored as previously
described (Liu et al., 2015). Total RNA was extracted with TRIzol®
(Invitrogen Life Technologies, USA), and the quantity was measured
with the NanoDrop® ND-1000 spectrophotometer. Reverse tran-
scription was  performed in accordance with the speciﬁcation of
Mir-XTM miRNA First-Strand Synthesis kit (Takara, Dalian, China),
using Gene Amp  PCR System 9700 (Applied Biosystems) at 16 ◦C
for 30 min, 42 ◦C for 40 min, and 85 ◦C for 5 min. PCR reactions
were performed with Mir-X miRNA qRT-PCR SYBR Kit (Takara,
Dalian, China), using Light Cycler 480 Real-time PCR(12.5 l 2x
SYBR Advantage premix, 0.5 l 50x ROX Dye, 0.5 l 10 M miRNA-
speciﬁc Primer, 0.5 l mRQ  3′ Primer, 2.0 l of template cDNA, and
9 l RNase-free H2O to 25 l in total) at 95 ◦C for 10 s, 40 cycles
of 95 ◦C for 5 s and 60 ◦C for 20 s, followed by 95 ◦C for 60 s, and
55 ◦C for 30 s. The speciﬁc primer for miR-328a was  designed and
produced by Dalian biotethnology Co. Ltd. Dalian Takara (Dalian,
China), and U6 was  used as the internal control. The relative
expression quantity of miR-328a was  calculated using relative val-
ues of cycle threshold (CT) normalized to that of U6 as 2−CT
(Ct = C samples − Ct meanvalueofsamplesfromtheshamgroup).
2.5. Target gene prediction and western blotting analysis
Target genes of miR-328a were predicted by the application of
bioinformatics analysis (TargetScan), and those that might take
a role in cognitive dysfunction were selected for further study.
The expressions of BACE in hippocampi from all experimental
rats were investigated using Western blotting. The hippocampal
tissues were homogenized in an ice-cold mixture of RIPA buffer
(Beyotime, Haimen, China) and protease inhibitors, and then incu-
bated over ice for 30 min. After the centrifugation, the supernatant
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f the homogenates was collected, and the concentration of total
rotein was detected by BCA Protein Assay kit. Samples contain-
ng an equal quantity of denatured protein (50 g) were loaded,
nd were then electrophoresed in 10% SDS-PAGE, followed by
lectrophoretic transference onto 0.45 mm PVDF membranes (Mil-
ipore Corp, Bellerica, Massachusetts) by the method of semi-dry
ransfer. Membranes with proteins were blocked with 5% skim milk
nd TRIS buffered saline plus Tween 20 (TBST: 20 mM Tris/HCl,
50 mM NaCl, 0.1% Tween 20, pH 7.4) solution for 1 h at room
emperature, and then incubated with monoclonal mouse anti-
ACE antibody (1:600; Santa Cruz Blotechnology, CA, USA) or rabbit
ntibody against GAPDH (1:3000, Cell Signaling Technology, USA)
vernight at 4 ◦C. After 10min-wash for 3 times in TBST, membranes
ere then incubated with secondary anti-mouse antibody (1:5000,
ell Signaling Technology, USA) or secondary anti-rabbit antibody
1:10,000, Cell Signaling Technology, USA) for 1 h at surrounding
emperature. Signals were detected using LI-COR Odyssey imag-
ng system (LI-COR Biosciences, USA) in 800 nm channel, and the
ensity of each immunoreactive band normalized to corresponding
APDH was measured using the LI-COR Odyssey analysis software.
. Statistical analysis
All results are presented as the mean ± standard deviation (SD).
ata in this study, including the escape latency on day 5, the time
nd distance in the target quadrant on day 6 in the MWM  test,
he comparative cycle threshold in RT-qPCR, and the comparative
ensity of immunoreactive bands in Western blot were analyzed by
ne-way ANOVA and the LSD test with SPSS 17.0 package (Chicago,
L, USA). Differences among groups were considered statistically
igniﬁcant only if the value of P < 0.05 (ANOVA).
. Results
.1. PTZ kindling
After the PTZ administration, rats with the behavioral changes
eaching levels IV–V of the Racine standard were considered as TLE
odels (n = 36). After the assessment of memory behavior by the
WM test, half of the rats were randomly selected from each group
nd were sacriﬁced for RT-qPCR while the other half was  evaluated
y Western blotting analysis.
.2. Morris water maze test
The escape latency of all the 4 groups lessened progressively
uring 5 training days (Fig. 1A). The escape latency on the 5th day,
he swimming distance and the time that rats spent in the target
uadrant were all analyzed to determine the differentials of the
patial memory ability among the 4 groups. As shown in Fig. 1A,
ompared to the sham group (16.02 ± 6.79 s), the 5th-day latency
f the PTZ group (25.47 ± 9.81 s) was longer (P < 0.05). There were
o statistical differences between the PTZ group and antagomir-
ontrol group (24.48 ± 5.73 s, P > 0.05). Latency of the antagomir
roup on the 5th day (34.10 ± 11.77 s) was longer than that of the
ntagomir-control group (P < 0.05).
In the Spatial probe test, the platform was removed. As shown
n Fig. 1B and 1C, compared to the sham group (39.64 ± 9.22 s),
he time that the PTZ group (32.40 ± 8.86 s) spent in the target
uadrant (SE) was shorter (P < 0.05). There was no statisti-
al difference between the PTZ group and antagomir-control
roup (31.89 ± 6.98 s, P > 0.05). The time that the antagomir
roup (24.16 ± 6.64 s) spent in SE was shorter than that of
he antagomir-control group (P < 0.05). Compared to the sham
roup (596.60 ± 151.48 cm), the distance that the PTZ groupletin 125 (2016) 205–210 207
(472.91 ± 96.48 cm)  swam in SE was shorter (P < 0.05). There were
no statistical differences between the PTZ group and antagomir-
control group (494.70 ± 99.81 cm,  P > 0.05). The distance that the
antagomir group (368.60 ± 114.74 cm)  swam in SE was  shorter than
that of the antagomir-control group (P < 0.05). The representative
pathways of rats from 4 groups in the probe test are shown in
Fig. 1D. Rats from the antagomir group could hardly locate the
target quadrant correctly. The data indicated that there was mem-
ory impairment in PTZ-kindled rats, and giving them the miR-328a
antagomir could further impair the memory ability in PTZ-kindled
rats.
4.3. RT-qPCR for miR-328a and target gene prediction
As shown in Fig. 2A, miR-328a levels in the hippocampus of
rats from the sham group (2−CT = 1.03 ± 0.29) were higher than
those from the PTZ group (2−CT = 0.74 ± 0.20, P < 0.05), which is
consistent with the previous study (Liu et al., 2015). There was
no signiﬁcant statistical difference between the PTZ group and
the antagomir-control group (2−CT = 0.73 ± 0.29, P > 0.05). Addi-
tionally, the miR-328a levels of the antagomir-control group were
higher than those from the antagomir group (2−CT = 0.43 ± 0.14,
P < 0.05). The data indicated that the expression of miR-328a was
down-regulated in PTZ-kindled rats, and giving them the miR-328a
antagomir could further decrease the miR-328a levels.
The downstream gene of miR-328a was predicted using Tar-
getScan. BACE1, SYNGAP1, GTPBP2 and BCL9L, etc. were predicted
to be the potential downstream gene. As shown in Fig. 2B, miR-328a
has conserved and strong binding sites on the position 408–415 nt
of the BACE1 3′ untranslated region (UTR).
4.4. Western blotting analysis for the expression of BACE in the
hippocampus
Western blotting was performed to determine the expression
of BACE in the hippocampus and to assess the differences among
the 4 groups. As shown in Fig. 3A, compared to the sham group,
the expression of BACE of the PTZ group was up-regulated, and
that of the antagomir group was  higher than that of the antagomir-
control group. Fig. 3B showed that the expression of BACE of the
PTZ group increased 0.65-fold over that of the sham group, and the
expression of the antagomir group increased 0.38-fold over that
of the antagomir-control group. There was  no signiﬁcant statisti-
cal difference between the PTZ group and the antagomir-control
group (P > 0.05). The data indicated that the expression of BACE
was up-regulated in PTZ-kindled rats, and the down-regulation of
miR-328a could further increase the BACE levels.
5. Conclusion
The expression of miR-328a in PTZ-kindled rats was  down-
regulated. MiR-328a could regulate the cognitive function of rats.
The down-regulation of miR-328a contributed to the cognitive dys-
function of PTZ-kindled rats by up-regulating the BACE levels and
this linked the PTZ model with Alzheimer’s disease.
6. Discussion
6.1. A novel factor that contributes to the cognitive dysfunction in
TLEA large proportion of TLE patients is suffers from varying lev-
els of cognitive deﬁcit including learning and memory impairment
(Seidenberg et al., 2007). However, the underlying mechanism of
this prevalent phenomenon is vague. Previous studies have shown
208 Y. Liao et al. / Brain Research Bulletin 125 (2016) 205–210
Fig. 1. Morris water maze test. The spatial learning and memory ability of rats were tested and analyzed by Morris water maze (n = 12 for each group). (A): The time rats
spent  to ﬁnd the platform during 5 training days. (B): The time rats spent in the target quadrant (SE) in the probe test. (C): The distance rats swam in the target quadrant (SE)
in  the probe test. (D): The routes of rats in the probe test. Results are presented as the mean ± standard deviation (SD). *: P < 0.05.
Fig. 2. RT-qPCR for miR-328a and Target Gene Prediction. (A): Expression of miR-328a in 4 groups (n = 6 for each group). (B): The predicted binding sites on the position
408–415  nt of the BACE1 3′ untranslated region (UTR). Results are presented as the mean ± standard deviation (SD). *: P < 0.05.
Y. Liao et al. / Brain Research Bulletin 125 (2016) 205–210 209
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mig. 3. Western Blotting Analysis for the expression of BACE in the hippocampus. T
ach  group). (A): Expression of BACE in the hippocampus. (B): Statistical analysis of
eviation (SD). *: P < 0.05.
hat this feature of epilepsy may  relate to the seizures themselves
r AEDs, etc. (Majak and Pitkanen, 2004; Onuma, 2011). Our earlier
tudy was the ﬁrst attempt to reveal and explain this phenomenon
hrough detecting the changes of hippocampal microRNAs. As
he result of miRNA microarray analysis of TLE rats with mem-
ry impairment, 4 microRNAs showed up-regulation (miR-34c,
iR-181a, miR-374, and miR-let-7c-1), and 7 microRNAs showed
own-regulation (miR-127-5p, miR-328a, miR-331, miR-375, miR-
70-5p, miR-1188, and miR-873-5p) (Liu et al., 2015). Whether
hese variations contribute to the cognitive dysfunction remains
nknown. The decrease of miR-328a was conﬁrmed using RT-qPCR
n this study. After the miR-328a antagomir administration, the
earning and memory ablity of the TLE rats were impaired, which
ndicated that miR-328a might regulate cognitive function in TLE.
.2. A molecular pathway that might work both in Alzheimer’
isease and epilepsy
AD is known as an age-related neurodegenerative disorder char-
cterized by cognitive dysfunction. Over the last few decades, the
elationship between AD and epilepsy, especially TLE, has attracted
reat attention due to some shared physical, cognitive and men-
al manifestation. In early studies, recurrent spontaneous seizures
ere considered as the consequence of AD because the occurrence
ate of seizures in people with AD is much higher than that in regu-
ar populations. Additionally, different types of seizures occurred in
eople with AD indicating that the electrical discharges in the brain
ere somehow triggered in the development of AD (Larner, 2010;
alop and Mucke, 2009; Rao et al., 2009). Interestingly, studies of
ransgenic AD mice showed that before the Abeta peptides accumu-
ated, the epileptic seizures had occurred several times already. In
ddition, the transgenic AD mice did not appear to suffer from sig-
iﬁcant seizures without the accumulation of Abeta peptides (Palop
t al., 2007; Roberson et al., 2011). These results indicated that as
D developed, the occurrence of epilepsy might play an assistant
ole in the production and accumulation of amyloid beta peptides.
owever, the underlying mechanism of this effect remains unclear.
he results shown in this study suggested that part of the molecular
athway in AD might also work in epilepsy. As the beta-secretase
f APP, the BACE levels will signiﬁcantly affect the development of
D, and that makes BACE a potential target of the treatment of AD
Vassar et al., 1999). Thus, the cognitive dysfunction and the down-
egulation of miR-328a plus the up-regulation of BACE link the PTZ
odel with Alzheimer’s disease.pocampal BACE levels were investigated using western blotting analysis (n = 6 for
campal BACE levels among 4 groups. Results are presented as the mean ± standard
6.3. Orientation of future research
As shown in a previous study, miR-328 was  found to be down-
regulated in APPSwe/PS1 mice, and effectively regulating the BACE
levels (Boissonneault et al., 2009), which is consistent with the
results of our study. Just as we ﬁnd increasing expression levels and
enzymatic activity of BACE in the development of AD (Yang et al.,
2003), with the prolongation of time, epilepsy might ﬁnally develop
into an Abeta-accumulation situation in a similar way. Therefore,
the pathological changes in brains, especially the expression lev-
els and morphology changes of Abeta peptides in patients with TLE
should be paid more attention in the further research. To study how
the brains of epileptics will develop, the detection of Abeta pep-
tides levels on the basis of the establishment of long-term TLE rat
models is necessary. Furthermore, as presented in previous stud-
ies, the cause of cognitive dysfunction in epilepsy is primarily the
seizures themselves (Majak and Pitkanen, 2004), so regular med-
ication dealing with the seizures was also considered to take care
of the cognitive dysfunction. Interestingly, in recent studies, some
AEDs like levetiracetam and some sodium channel blocking AEDs
can play a positive role in AD (Bakker et al., 2012; Ziyatdinova et al.,
2011). As a result, drugs contributing to the improvement of both
epilepsy and AD are drawing more and more attention. In con-
clusion, besides the regular therapy of epilepsy, there are deeper
studies required to be done dealing with the cognitive deﬁciency,
like the role that miR-328a plays in TLE.
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